Covance Closes Acquisition of Merck Gene Expression Group | GenomeWeb

NEW YORK (GenomeWeb News) – Clinical research and pharmaceutical services firm Covance said yesterday that it has closed its acquisition of Merck's Seattle-based gene expression lab.

The financial terms of the purchase, announced last month, were not disclosed, but Merck has agreed to purchase of a five-year genomic analysis services contract worth $145 million as part of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.